Search research articles
Contact Us
Filters
Showing results (131-140 of 151) with videos related to
Page
of 16
Sort By:
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|
August 20, 2004
[Analysis of the problem of "difficult hospital discharges" in the University Hospital of Parma]
Tiziana Meschi, Enrico Fiaccadori, Silvia Cocconi, et al.
Asia-Pacific Journal of Oncology Nursing
|
July 2, 2019
Scalp Cooling in Daily Clinical Practice for Breast Cancer Patients Undergoing Curative Chemotherapy: A Multicenter Interventional Study
Emilia Gianotti, Giorgia Razzini, Manuela Bini, et al.
Antimicrobial Resistance and Infection Control
|
February 26, 2026
Application of next-generation sequencing to investigate a Serratia marcescens outbreak in a neonatal intensive care unit
Michela Bulfoni, Nicolò Gualandi, Beatrice Krpan, et al.
British Journal of Cancer
|
July 2, 1998
Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group
M Bontenbal, M Andersson, J Wildiers, et al.
American Journal of Clinical Oncology
|
April 8, 2006
Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer: the role of anthracycline dose intensity
Cecilia Bozzetti, Antonino Musolino, Roberta Camisa, et al.
Frontiers in Medicine
|
December 6, 2023
A look at the past to draw lessons for the future: how the case of an urgent ICU transfer taught us to always be ready with a plan B
Laura Brunelli, Edoardo Miotto, Massimo Del Pin, et al.
JMIR Mhealth and Uhealth
|
April 29, 2025
mHealth Apps Available in Italy to Support Health Care Professionals in Antimicrobial Stewardship Implementation: Systematic Search in App Stores and Content Analysis
Giuseppa Russo, Annachiara Petrazzuolo, Marino Trivisani, et al.
American Journal of Clinical Oncology
|
December 22, 1999
Mature results of a prospective randomized trial comparing a three-weekly with an accelerated weekly schedule of cisplatin in advanced ovarian carcinoma
G Cocconi, M Bella, R Lottici, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma
G Cocconi, P Carlini, A Gamboni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1997
Double-blind, multicenter, randomized trial to compare the effect of two doses of adrenocorticotropic hormone versus placebo in controlling delayed emesis after high-dose cisplatin in adult patients with cancer
R Passalacqua, G Cocconi, C Caminiti, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 151) with videos related to
Sort By:
Page
of 16
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|
August 20, 2004
[Analysis of the problem of "difficult hospital discharges" in the University Hospital of Parma]
Tiziana Meschi, Enrico Fiaccadori, Silvia Cocconi, et al.
Asia-Pacific Journal of Oncology Nursing
|
July 2, 2019
Scalp Cooling in Daily Clinical Practice for Breast Cancer Patients Undergoing Curative Chemotherapy: A Multicenter Interventional Study
Emilia Gianotti, Giorgia Razzini, Manuela Bini, et al.
Antimicrobial Resistance and Infection Control
|
February 26, 2026
Application of next-generation sequencing to investigate a Serratia marcescens outbreak in a neonatal intensive care unit
Michela Bulfoni, Nicolò Gualandi, Beatrice Krpan, et al.
British Journal of Cancer
|
July 2, 1998
Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group
M Bontenbal, M Andersson, J Wildiers, et al.
American Journal of Clinical Oncology
|
April 8, 2006
Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer: the role of anthracycline dose intensity
Cecilia Bozzetti, Antonino Musolino, Roberta Camisa, et al.
Frontiers in Medicine
|
December 6, 2023
A look at the past to draw lessons for the future: how the case of an urgent ICU transfer taught us to always be ready with a plan B
Laura Brunelli, Edoardo Miotto, Massimo Del Pin, et al.
JMIR Mhealth and Uhealth
|
April 29, 2025
mHealth Apps Available in Italy to Support Health Care Professionals in Antimicrobial Stewardship Implementation: Systematic Search in App Stores and Content Analysis
Giuseppa Russo, Annachiara Petrazzuolo, Marino Trivisani, et al.
American Journal of Clinical Oncology
|
December 22, 1999
Mature results of a prospective randomized trial comparing a three-weekly with an accelerated weekly schedule of cisplatin in advanced ovarian carcinoma
G Cocconi, M Bella, R Lottici, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 26, 2003
Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma
G Cocconi, P Carlini, A Gamboni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1997
Double-blind, multicenter, randomized trial to compare the effect of two doses of adrenocorticotropic hormone versus placebo in controlling delayed emesis after high-dose cisplatin in adult patients with cancer
R Passalacqua, G Cocconi, C Caminiti, et al.
Page
of 16